CFTR and autoimmune pancreatitis type 1: Steroid therapy can improve pancreatic exocrine function in type 1 AIP by suppressing inflammation and fibrosis, and regeneration by correcting aberrant localization of the cystic fibrosis transmembrane conductance regulator (CFTR) in the pancreatic duct cells, and stimulating the regeneration of acinar cells [51].